Epirubicin/Cisplatin (EC) or EC plus Taxol (TEC) in a two weekly regimenin patients with advanced ovarian carcinoma (AOVCA)

J.B Vermorken, K. Hoekman, E.W. Muller, R.V.H.P. Huijskes, C.W. Burger, RHM Verheijen, P. Kenemans, H.M. Pinedo

Research output: Contribution to conference › Abstract › Other research output

Original language	English
Publication status	Published - 1995
Event	5th International Congress on Anti-Cancer Chemotherapy - Paris, France Duration: 3 Apr 1995 → …

Conference	5th International Congress on Anti-Cancer Chemotherapy
Country/Territory	France
City	Paris
Period	3/04/95 → …

Cite this

@conference{5eb61b60b8ad40558e2980f073db882a,

title = "Epirubicin/Cisplatin (EC) or EC plus Taxol (TEC) in a two weekly regimenin patients with advanced ovarian carcinoma (AOVCA)",

author = "J.B Vermorken and K. Hoekman and E.W. Muller and R.V.H.P. Huijskes and C.W. Burger and RHM Verheijen and P. Kenemans and H.M. Pinedo",

year = "1995",

language = "English",

note = "5th International Congress on Anti-Cancer Chemotherapy ; Conference date: 03-04-1995",

}

TY - CONF

T1 - Epirubicin/Cisplatin (EC) or EC plus Taxol (TEC) in a two weekly regimenin patients with advanced ovarian carcinoma (AOVCA)

AU - Vermorken, J.B

AU - Hoekman, K.

AU - Muller, E.W.

AU - Huijskes, R.V.H.P.

AU - Burger, C.W.

AU - Verheijen, RHM

AU - Kenemans, P.

AU - Pinedo, H.M.

PY - 1995

Y1 - 1995

M3 - Abstract

T2 - 5th International Congress on Anti-Cancer Chemotherapy

Y2 - 3 April 1995

ER -